CERA

Science and Research

GOLDEN: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRX, an Antisense Inhibitor of Complement Factor B, in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

The research project is testing an experimental drug called ISIS 696844 for geographic atrophy secondary to age-related macular degeneration. 

Overview

The research project is testing an experimental drug called ISIS 696844 for geographic atrophy secondary to age-related macular degeneration.

The study drug is designed to slow the body’s production of the protein called Factor B (FB) that is made in the liver and found in the eye, which may contribute to GA secondary to AMD.

  • Principal Investigator
Professor Robyn Guymer AM

Learn more

View this study on ClinicalTrials.gov

This international database listing provides more detailed information about this study.